Related Experiment Video
Updated: Aug 16, 2026

Assessment of Social Interaction Behaviors
Published on: February 25, 2011
Role of nitric oxide on motor behavior
E A Del Bel1, F S Guimarães, M Bermúdez-Echeverry
1Department MEF Physiology, School of Odontology, Medical School, Campus USP, Ribeirao Preto, SP, Brazil. eadelbel@usp.br
Nitric oxide (NO) influences motor control by modulating neurotransmission. Inhibiting nitric oxide synthase (NOS) can cause catalepsy, suggesting NO
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Nitric oxide (NO) is implicated in various physiological processes, including motor control.
- Nitric oxide synthase (NOS) is the enzyme responsible for NO production.
- Previous studies suggest NO influences anxiety-like behaviors and exploration.
Purpose of the Study:
- To investigate the role of nitric oxide (NO) in motor control.
- To examine the effects of nitric oxide synthase (NOS) inhibitors on motor behavior.
- To explore the interaction of NO with dopaminergic, serotonergic, and cholinergic systems in motor regulation.
Main Methods:
- Administration of various NOS inhibitors (e.g., L-NOARG, L-NAME) in rodents (mice and rats).
- Behavioral testing including elevated plus maze, open field arena, and catalepsy assessment.
- Pharmacological manipulations involving dopamine D2 antagonists, serotonin receptor antagonists, and antimuscarinic drugs.
- Histological analysis of NADPH-d positive neurons in brain regions associated with motor control.
Main Results:
- NOS inhibitors induced catalepsy in mice and rats, suggesting motor impairment.
- Acute L-NOARG administration showed additive cataleptic effects with haloperidol and potentiation by certain receptor antagonists.
- Antimuscarinic drugs blocked L-NOARG-induced catalepsy.
- Subchronic NOS inhibition led to tolerance to cataleptic effects and cross-tolerance to haloperidol.
- Changes in NADPH-d neuronal density were observed in motor-related brain areas following subchronic NOS inhibition.
- NO appears to play a protective role in experimental Parkinson's disease models.
Conclusions:
- Nitric oxide (NO) modulates motor behavior, likely through interactions with striatal dopaminergic, serotonergic, and cholinergic neurotransmission.
- Subchronic inhibition of NO synthesis induces neuroplastic changes and may reduce motor side effects of antipsychotic medications.
- The NO system interacts with neurodegenerative processes in the nigrostriatal pathway, indicating a potential neuroprotective role for NO.
Related Concept Videos
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Neurochemical Transmission: Sites of Drug Action
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Enteric Nervous System: Regulation of GI Motor Activity
During periods of fasting, the ENS initiates the migrating myoelectric complex, a program...

